Ronald Crystal
Fondateur chez Xylocor Therapeutics, Inc.
Fortune : 22 M $ au 31/05/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Albert W. Gianchetti | M | 59 |
Xylocor Therapeutics, Inc.
 Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
| Jennifer Augusti | F | - |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
| Derace L. Schaffer | M | 76 |
Weill Cornell Medical College
| - |
| Todd K. Rosengart | M | - |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | 11 ans |
| Costantino Iadecola | M | - |
Weill Cornell Medical College
| - |
| Lorraine Gudas | F | - |
Weill Cornell Medical College
| - |
| Donald J. D'Amico | M | - |
Weill Cornell Medical College
| - |
| Nelson Peltz | M | 81 |
Weill Cornell Medical College
| - |
| Felice Schnoll Sussman | M | 54 |
Weill Cornell Medical College
| 11 ans |
| Michael Zelefsky | M | 63 |
Weill Cornell Medical College
| 30 ans |
| Ross Levine | M | 52 |
Weill Cornell Medical College
| 17 ans |
| Mozah bint Nasser Al-Missned | F | 66 |
Weill Cornell Medical College
| - |
| Todd Caven | M | 61 |
Weill Cornell Medical College
| - |
| Steven A. Kaplan | M | 66 |
Weill Cornell Medical College
| 13 ans |
| Richard Pasternak | M | 75 |
Weill Cornell Medical College
| - |
| Francis Barany | M | - |
Weill Cornell Medical College
| - |
| Madelyn Antoncic | M | 71 |
Weill Cornell Medical College
| - |
| Guillermo Torre-Amione | M | - |
Weill Cornell Medical College
| - |
| Louis Aronne | M | 69 |
Weill Cornell Medical College
| 38 ans |
| Thomas H. Lee | M | 70 |
Weill Cornell Medical College
| - |
| Cheryl Pegus | M | 60 |
Weill Cornell Medical College
| - |
| Sharon J. Parish | M | - |
Weill Cornell Medical College
| - |
| Gail J. Roboz | F | - |
Weill Cornell Medical College
| - |
| Scott T. Tagawa | M | - |
Weill Cornell Medical College
| 17 ans |
| Dmitri Konon | M | - |
Weill Cornell Medical College
| - |
| Mark Lachs | M | - |
Weill Cornell Medical College
| - |
| Javier Pinto | M | - |
Weill Cornell Medical College
| - |
| Raul Martinez-McFaline | M | - |
Weill Cornell Medical College
| - |
| Larry Schlossman | M | - |
Weill Cornell Medical College
| - |
| Sophie McKenney | F | - |
Weill Cornell Medical College
| - |
| Adam Garriga | M | - |
Weill Cornell Medical College
| - |
| Olaf Andersen | M | - |
Weill Cornell Medical College
| - |
| James B Bussel | M | - |
Weill Cornell Medical College
| - |
| Melissa Nirenberg | F | - |
Weill Cornell Medical College
| - |
| Manuel Hidalgo Medina | M | 56 |
Weill Cornell Medical College
| 5 ans |
| Jonathan Hale Zippin | M | 48 |
Weill Cornell Medical College
| 14 ans |
| Paolo Manfredi | M | 62 |
Weill Cornell Medical College
| - |
| Lizzie Ngo | M | - |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
| Nikhil Thatte | M | - |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
| Hedvig Hricak | M | 77 |
Weill Cornell Medical College
| 24 ans |
| Joan H. Weill | F | - |
Weill Cornell Medical College
| - |
| Linda T. Vahdat | M | - |
Weill Cornell Medical College
| - |
| Robert Glassman | M | 62 |
Weill Cornell Medical College
| - |
| Sanford Weill | M | 91 |
Weill Cornell Medical College
| 29 ans |
| Anne Evans-Estabrook | F | 79 |
Weill Cornell Medical College
| - |
| Stanley Zinberg | M | 89 |
Weill Cornell Medical College
| - |
| Antonio Gotto | M | 88 |
Weill Cornell Medical College
| 27 ans |
| Ronald Perelman | M | 81 |
Weill Cornell Medical College
| - |
| John Mack | M | 79 |
Weill Cornell Medical College
| - |
| John Adam Kanas | M | 77 |
Weill Cornell Medical College
| - |
| James Kilts | M | 76 |
Weill Cornell Medical College
| - |
| R. Gordon Douglas | M | 89 |
Weill Cornell Medical College
| - |
| Michael T. Masin | M | 79 |
Weill Cornell Medical College
| 21 ans |
| Ajaypal Banga | M | 65 |
Weill Cornell Medical College
| - |
| Alan Colowick | M | 61 |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | 6 ans |
| Alastair J. J. Wood | M | 77 |
Weill Cornell Medical College
| - |
| A. Davis | M | 57 |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
| Mitchell Blutt | M | 66 |
Weill Cornell Medical College
| - |
| Jeffrey Greenberg | M | 56 |
Weill Cornell Medical College
| - |
| Morton Coleman | M | 81 |
Weill Cornell Medical College
| 38 ans |
| David Scheinberg | M | 68 |
Weill Cornell Medical College
| 25 ans |
| Paul Gould | M | 77 |
Weill Cornell Medical College
| - |
| Daniel L. Lorber | M | 77 |
Weill Cornell Medical College
| - |
| Lewis Cantley | M | 75 |
Weill Cornell Medical College
| 12 ans |
| Aidan King | M | 53 |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | 3 ans |
| Robert Spiegel | M | 73 |
Weill Cornell Medical College
| 11 ans |
| Benny Soffer | M | 52 |
Weill Cornell Medical College
| - |
| John Paul de Koning | M | 55 |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
| Daniel Winter Goodman | M | 63 |
Weill Cornell Medical College
| - |
| Daniel Hetu | M | - |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
| Rajat K. Gupta | M | 75 |
Weill Cornell Medical College
| - |
| Fouad Azzam | M | 57 |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
| Chelsea Clinton | M | 44 |
Weill Cornell Medical College
| 12 ans |
| Kenneth A. Buckfire | M | - |
Weill Cornell Medical College
| - |
| Calvin Roberts | M | 71 |
Weill Cornell Medical College
| 42 ans |
| David Helfet | M | 77 |
Weill Cornell Medical College
| - |
| Holly G. Atkinson | M | - |
Weill Cornell Medical College
| - |
| Bruce Ratner | M | 79 |
Weill Cornell Medical College
| - |
| Glenn Batchelder | M | 63 |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
| Ngai Chiu Tse | M | 57 |
Weill Cornell Medical College
| - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Michael Carson | M | - |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | 2 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 81 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Ronald Crystal
- Réseau Personnel
